3720 Spectrum Blvd., Suite 125, Tampa, FL 33612
Ph.D.
Chairman/CEO
Dr. Navdeep Jaikaria has been at the forefront of cutting-edge biotechnologies in his various professional roles and has trained at some of the finest institutions in India and the US and with leading scientists of his times. Before founding SGN, Dr. Jaikaria was Managing Director and Head of Equity Research at a leading Healthcare Investment Bank in New York, where he led a team of about 30 equity research analysts. Dr. Jaikaria successfully used his scientific acumen and expertise to consistently identify and value ground-breaking therapies and biopharma technologies as successful investment opportunities in his Wall Street career spanning almost ten years. During his career, he has successfully assembled & managed competent teams of scientific experts and business professionals in high-pressure, productivity-focused environments.
Dr. Jaikaria’s industry & investment perspectives have been widely cited in the print & broadcast media including The Wall Street Journal, Financial times, Businessweek, Forbes. He periodically appeared as a guest commentator on CNNfn, CNBC, CNN India and has provided policy input to the US senate health committee on biodefense. He was named as one of the five best stock-pickers in Biotechnology in the Wall Street Journal’s annual “Best on the Street” Analysts survey in 2007 and was consistently ranked as a top Biotech analyst on Wall Street.
Dr. Jaikaria obtained B.Sc. in Human Biology from the All India Institute of medical Sciences, New Delhi, his Ph.D. from New York Medical College and was a Post-Doctoral Fellow at The Rockefeller University, New York. He has won many academic awards throughout, including the Martha Lucas Pate, Ph.D. Memorial Award for academic excellence & leadership at the New York Medical College, the Naval Research Scholarship to conduct research at Stanford University, and was awarded the prestigious National Talent Search Scholarship – the highest scholastic award in India after high school. He was ranked #2 overall at the All India Institute of Medical Sciences.
Over the years, Navdeep is/has been a member of Non-for-profit and Corporate Boards (both Private and Public).
Ph.D.
Vice President R&D
Dr. Pranav Patel is a highly experienced scientist who leads the SGN R&D team and brings over 25 years of extensive R&D experience in the pharmaceutical industry, spanning several domains such as synthetic chemistry, formulation sciences, analytical sciences, and GMP manufacturing. He has a strong track record, leading the successful development of numerous pharmaceutical products that have obtained marketing approval from the US Food and Drug Administration (FDA). Dr. Patel holds a Ph.D. in Medicinal Chemistry from the Florida Institute of Technology, under the mentorship of Dr. Joshua Rokach, a well-renowned Isoprostanes & Prostaglandins pioneer (former President, Merck & Co., who led the discovery of the asthma drug “Singulair”).
Dr. Patel’s contributions and achievements in pharmaceutical research and development have positioned him as a knowledgeable and respected professional in the industry. Currently, he is also a Collaborative Professor, Dept. of Molecular Medicine, Morsani College of Medicine, University of South Florida Health; Assistant Professor, Affiliate, Dept. of Pharmaceutical Sciences, USF college of Pharmacy and, a Committee Member, Industry Advisory Council (IAC), USF Health. Through his expertise and dedication, Dr. Patel continues to make significant contributions to advancing healthcare and improving patient outcomes.
M.D., DM.
Clinical Development & Regulatory Consultant
Ph.D.
Chairman/CEO
M.D.
Ph.D., MBA


